These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 27978985)

  • 1. Translational biomarkers: from discovery and development to clinical practice.
    Subramanyam M; Goyal J
    Drug Discov Today Technol; 2016; 21-22():3-10. PubMed ID: 27978985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulatory Forum Opinion Piece*: Veterinary Pathologists in Translational Pharmacology and Biomarker Integration in Drug Discovery and Development.
    Ramaiah SK; Walker DB
    Toxicol Pathol; 2016 Feb; 44(2):137-46. PubMed ID: 26839329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Translational medicine--a paradigm shift in modern drug discovery and development: the role of biomarkers.
    Day M; Rutkowski JL; Feuerstein GZ
    Adv Exp Med Biol; 2009; 655():1-12. PubMed ID: 20047030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety biomarkers in preclinical development: translational potential.
    Sasseville VG; Mansfield KG; Brees DJ
    Vet Pathol; 2014 Jan; 51(1):281-91. PubMed ID: 24091814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometry-based biomarkers in drug development.
    Miller RA; Spellman DS
    Adv Exp Med Biol; 2014; 806():341-59. PubMed ID: 24952191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improving treatment of neurodevelopmental disorders: recommendations based on preclinical studies.
    Homberg JR; Kyzar EJ; Stewart AM; Nguyen M; Poudel MK; Echevarria DJ; Collier AD; Gaikwad S; Klimenko VM; Norton W; Pittman J; Nakamura S; Koshiba M; Yamanouchi H; Apryatin SA; Scattoni ML; Diamond DM; Ullmann JF; Parker MO; Brown RE; Song C; Kalueff AV
    Expert Opin Drug Discov; 2016; 11(1):11-25. PubMed ID: 26558752
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of translational risk in drug research: Role of biomarker classification and mechanism-based PKPD concepts.
    Visser SAG; Bueters TJH
    Eur J Pharm Sci; 2017 Nov; 109S():S72-S77. PubMed ID: 28811131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The discovery and development of proteomic safety biomarkers for the detection of drug-induced liver toxicity.
    Amacher DE
    Toxicol Appl Pharmacol; 2010 May; 245(1):134-42. PubMed ID: 20219512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. General overview: biomarkers in neuroscience research.
    Filiou MD; Turck CW
    Int Rev Neurobiol; 2011; 101():1-17. PubMed ID: 22050846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic and systems approaches to translational biomarker discovery in immunological diseases.
    MacIsaac KD; Wang IM; Menetski J; Roberts C
    Drug Discov Today; 2014 Feb; 19(2):133-9. PubMed ID: 24126144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotopic biomarker discovery and application in translational medicine.
    Bayele HK; Chiti A; Colina R; Fernandes O; Khan B; Krishnamoorthy R; Ozdağ H; Padua RA
    Drug Discov Today; 2010 Feb; 15(3-4):127-36. PubMed ID: 20038454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translation of neurological biomarkers to clinically relevant platforms.
    Hayes RL; Robinson G; Muller U; Wang KK
    Methods Mol Biol; 2009; 566():303-13. PubMed ID: 20058180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimising translational oncology in clinical practice: strategies to accelerate progress in drug development.
    Stahel R; Bogaerts J; Ciardiello F; de Ruysscher D; Dubsky P; Ducreux M; Finn S; Laurent-Puig P; Peters S; Piccart M; Smit E; Sotiriou C; Tejpar S; Van Cutsem E; Tabernero J
    Cancer Treat Rev; 2015 Feb; 41(2):129-35. PubMed ID: 25533737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and challenges of disease biomarkers: a new section in the Journal of Translational Medicine.
    Wang X; Ward PA
    J Transl Med; 2012 Dec; 10():240. PubMed ID: 23217078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Translational paradigms in pharmacology and drug discovery.
    Mullane K; Winquist RJ; Williams M
    Biochem Pharmacol; 2014 Jan; 87(1):189-210. PubMed ID: 24184503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applications of 'decisionable' biomarkers in cardiovascular drug development.
    Krishna R; Wagner JA
    Biomark Med; 2010 Dec; 4(6):815-27. PubMed ID: 21133701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Translational research: the changing landscape of drug discovery.
    Fishburn CS
    Drug Discov Today; 2013 May; 18(9-10):487-94. PubMed ID: 23247258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Translational bioinformatics and systems biology approaches for personalized medicine.
    Yan Q
    Methods Mol Biol; 2010; 662():167-78. PubMed ID: 20824471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pathology in drug discovery and development.
    Jubb AM; Koeppen H; Reis-Filho JS
    J Pathol; 2014 Jan; 232(2):99-102. PubMed ID: 24122335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.